Medtronic Net Change in Cash decreased by 196.6% to -$945.00M in Q2 2025 compared to the prior quarter. Year-over-year, this metric declined by 3600.0%, from $27.00M to -$945.00M. Over 3 years (FY 2021 to FY 2025), Net Change in Cash shows an upward trend with a 19.5% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
A positive change indicates net cash generation, while a negative change indicates cash consumption for the period.
The total net increase or decrease in cash, cash equivalents, and restricted cash during the reporting period. It is the...
A fundamental liquidity metric used to compare cash management efficiency across all public companies.
net_change_in_cash| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$1.48B | -$589.00M | $1.70B | -$1.23B | $235.00M | -$1.57B | $1.04B | -$2.98B | -$204.00M | $314.00M | -$30.00M | -$339.00M | $27.00M | -$963.00M | $892.00M | $978.00M | -$945.00M |
| QoQ Change | — | +60.3% | +389.1% | -172.1% | +119.1% | -769.8% | +166.1% | -386.4% | +93.2% | +253.9% | -109.6% | <-999% | +108.0% | <-999% | +192.6% | +9.6% | -196.6% |
| YoY Change | — | — | — | — | +115.8% | -167.2% | +184.7% | <-999% | +87.0% | — | -102.9% | +88.6% | +113.2% | -406.7% | >999% | +388.5% | <-999% |